Sundrug Co.,Ltd. (TYO:9989)
Japan · Delayed Price · Currency is JPY | Market Cap | 434.24B -23.3% |
| Revenue (ttm) | 850.15B +4.3% |
| Net Income | 31.47B +0.2% |
| EPS | 268.97 +0.2% |
| Shares Out | 116.98M |
| PE Ratio | 13.80 |
| Forward PE | 12.81 |
| Dividend | 132.00 (3.61%) |
| Ex-Dividend Date | Sep 29, 2026 |
| Volume | 546,400 |
| Open | 3,726.00 |
| Previous Close | 3,717.00 |
| Day's Range | 3,695.00 - 3,746.00 |
| 52-Week Range | 3,526.00 - 4,883.00 |
| Beta | 0.10 |
| Analysts | Buy |
| Price Target | 4,704.29 (+26.73%) |
| Earnings Date | Aug 14, 2026 |
About Sundrug
Sundrug Co.,Ltd. engages in the drug store business in Japan. It operates through Drug Store Business and Discount Store Business segments. The Drug Store Business segment primarily sells pharmaceutical products, cosmetics, and daily necessities. The Discount Store Business segment offers food and household goods. The company was incorporated in 1957 and is headquartered in Fuchu, Japan. [Read more]
Financial Performance
In fiscal year 2026, Sundrug's revenue was 842.51 billion, an increase of 5.08% compared to the previous year's 801.81 billion. Earnings were 31.39 billion, an increase of 2.09%.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for 9989 stock is "Buy." The 12-month stock price target is ¥4,704, which is an increase of 26.73% from the latest price.
News
Sundrug initiated with a Hold at Jefferies
Jefferies initiated coverage of Sundrug with a Hold rating and 4,300 yen price target. The analyst is bullish on Japan’s retail sector, and within its subsectors, it believes department stores